Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Express Scripts
McKinsey
Mallinckrodt
Colorcon

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for DULOXETINE

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for DULOXETINE (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $69,611,842
INSIDE ANOTHER STORE $309,166,137
[disabled in preview] $1,492,890,363
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 776,867
INSIDE ANOTHER STORE 3,983,804
[disabled in preview] 11,347,597
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $181,894,772
MEDICARE $802,811,872
[disabled in preview] $887,083,629
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for DULOXETINE
Drug Units Sold Trends for DULOXETINE

Annual Sales Revenues and Units Sold for DULOXETINE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
DULOXETINE   See Pricing   See Pricing 2017
DULOXETINE   See Pricing   See Pricing 2016
DULOXETINE   See Pricing   See Pricing 2015
DULOXETINE   See Pricing   See Pricing 2014
DULOXETINE   See Pricing   See Pricing 2013
DULOXETINE   See Pricing   See Pricing 2012
DULOXETINE   See Pricing   See Pricing 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Baxter
Merck
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.